APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 188 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.45 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30 | +172.7% | 797 | +564.2% | 0.02% | +187.5% |
| Q2 2023 | $11 | 0.0% | 120 | -29.0% | 0.01% | -20.0% |
| Q1 2023 | $11 | -38.9% | 169 | -50.0% | 0.01% | +42.9% |
| Q4 2022 | $18 | -99.8% | 338 | +91.0% | 0.01% | -36.4% |
| Q3 2022 | $12,000 | 0.0% | 177 | -35.6% | 0.01% | +10.0% |
| Q2 2022 | $12,000 | -14.3% | 275 | -0.4% | 0.01% | +11.1% |
| Q1 2022 | $14,000 | +1300.0% | 276 | +1352.6% | 0.01% | +800.0% |
| Q4 2021 | $1,000 | – | 19 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 1,114,962 | $63,776,000 | 24.13% |
| Octagon Capital Advisors LP | 548,374 | $31,367,000 | 10.87% |
| Ghost Tree Capital, LLC | 325,000 | $18,590,000 | 4.14% |
| Burrage Capital Management LLC | 81,357 | $4,654,000 | 3.55% |
| Aufman Associates Inc | 53,642 | $3,068,000 | 2.75% |
| ACUTA CAPITAL PARTNERS, LLC | 167,054 | $9,555,000 | 2.60% |
| Cormorant Asset Management, LP | 1,866,108 | $106,741,000 | 2.54% |
| Tri Locum Partners LP | 121,409 | $6,945,000 | 2.52% |
| venBio Partners LLC | 490,471 | $28,055,000 | 2.48% |
| HHLR ADVISORS, LTD. | 5,028,289 | $287,618,000 | 2.29% |